Biolife Solutions Inc (BLFS) insider trading.
In Q3 2026, insiders at Biolife Solutions Inc reported 12 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-22
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Wichterman Troy | Officer · Chief Financial Officer | 3 | 0 | 0 |
| Mathew Aby J. | Officer · EVP & Chief Scientific Officer | 3 | 0 | 0 |
| Berard Todd | Officer · Chief Marketing Officer | 3 | 0 | 0 |
| Werner Sean | Officer · Chief Technology Officer | 2 | 0 | 0 |
| De Greef Roderick | Director, Officer · President and CEO | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-18 | Wichterman Troy | F (D) | 937 | $36.69 | 211,286 | Form 4 |
| 2026-09-18 | De Greef Roderick | F (D) | 2,775 | $36.69 | 728,196 | Form 4 |
| 2026-09-18 | Werner Sean | F (D) | 421 | $36.69 | 47,135 | Form 4 |
| 2026-09-18 | Mathew Aby J. | F (D) | 564 | $36.69 | 387,269 | Form 4 |
| 2026-09-18 | Berard Todd | F (D) | 470 | $36.69 | 161,823 | Form 4 |
| 2026-09-08 | Wichterman Troy | F (D) | 1,026 | $35.38 | 212,223 | Form 4 |
| 2026-09-08 | Mathew Aby J. | F (D) | 627 | $35.38 | 387,833 | Form 4 |
| 2026-09-08 | Berard Todd | F (D) | 356 | $35.38 | 162,293 | Form 4 |
| 2026-07-17 | Werner Sean | F (D) | 275 | $29.15 | 47,556 | Form 4 |
| 2026-07-07 | Berard Todd | F (D) | 293 | $27.79 | 162,649 | Form 4 |
| 2026-07-07 | Mathew Aby J. | F (D) | 516 | $27.79 | 388,460 | Form 4 |
| 2026-07-07 | Wichterman Troy | F (D) | 844 | $27.79 | 213,249 | Form 4 |
Transaction codes in this quarter
Get BLFS insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=834365&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · Biolife Solutions Inc on SEC.gov
Questions
Are insiders buying or selling Biolife Solutions Inc (BLFS)?
In Q3 2026, insiders at Biolife Solutions Inc reported 12 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Biolife Solutions Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/blfs.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.